Elizabeth C. Smith — Senior Vice President of Regulatory & Quality Assurance at Juno Therapeutics

Ms. Elizabeth C. Smith serves as a Senior Vice President of Regulatory & Quality Assurance at Juno Therapeutics Inc. Ms. Smith served as Senior Vice President of Regulatory Strategy and Portfolio Management at Juno Therapeutics Inc. Ms. Smith joined Juno in November 2013. Ms. Smith has over 20 years of experience in the field of regulatory affairs, quality, and manufacturing, with an emphasis on biologics and advanced cellular therapies in oncology. Ms. Smith served as a Vice President of Regulatory Affairs of Dendreon Corp. since December 30, 2002 and led the regulatory efforts resulting in FDA licensure of Provenge, the first approved active cellular therapy for the treatment of cancer. Ms. Smith served as Director of Regulatory affairs of Dendreon. She joined Dendreon in 1999. Ms. Smith worked at Genentech, Inc. as Regulatory Affairs Manager in manufacturing and facilities and at Immunex Corporation as a senior regulatory affairs associate. Prior to Dendreon, Ms. Smith held regulatory and manufacturing positions at Genentech and Immunex. She holds B.A. in Biology from Central Washington University.